Entera Bio (ENTX) Operating Leases (2019 - 2026)
Entera Bio (ENTX) posted quarterly Operating Leases of $263000.0 for Q1 2026, up 415.69% year-on-year from $51000.0 in Q1 2025, and up 1.15% on a QoQ basis from $260000.0 in Q4 2025.
Entera Bio (ENTX) Operating Leases (2019 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Operating Leases for 8 consecutive years, with $263000.0 the latest figure, recorded in Q1 2026.
- Quarterly Operating Leases rose 415.69% year-over-year to $263000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $263000.0 (up 415.69% YoY) and the FY2025 annual result came in at $260000.0, down 4.41% from the prior year.
- Operating Leases improved to $263000.0 in Q1 2026 per ENTX's latest filing, from $260000.0 in the prior quarter.
- Over the last five years, Operating Leases for ENTX reached as high as $456000.0 in Q2 2023 and fell as low as $3000.0 in Q3 2022.
- A 5-year average of $180687.5 and a median of $163000.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases sank 98.65% — and 2023, when it soared 13300.0%.
- Year by year, Operating Leases stood at $91000.0 in 2022, then soared by 328.57% to $390000.0 in 2023, then plunged by 30.26% to $272000.0 in 2024, then retreated by 4.41% to $260000.0 in 2025, then rose by 1.15% to $263000.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $263000.0, $260000.0, and $41000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263,000.00 |
| Dec 31, 2025 | 260,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 390,000.00 |
| Sep 30, 2023 | 402,000.00 |
| Jun 30, 2023 | 456,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 302,000.00 |
| Jun 30, 2021 | 371,000.00 |
| Dec 31, 2020 | 432,000.00 |
| Jun 30, 2020 | 81,000.00 |